首页> 外文期刊>Human Genetics >Cytogenetic studies in leprosy patients before and after chemotherapy
【24h】

Cytogenetic studies in leprosy patients before and after chemotherapy

机译:Cytogenetic studies in leprosy patients before and after chemotherapy

获取原文
       

摘要

The frequencies of chromosome aberrations and sister chromatid exchanges (SCEs), cell proliferation kinetics and mitotic indices were studied in peripheral blood lymphocyte cultures of leprosy patients both before and after chemotherapy. The differences in the frequencies of chromosome aberrations and SCEs between controls, paucibacillary and multibacillary patients were found to be statistically highly significant (P<0.001). The extent of cytogenetic damage seemed to depend on the severity of the disease. Lymphocytes of untreated leprosy patients showed a low mitotic index and a slow rate of cell proliferation. Following combined treatment with dapsone and rifampicin there was an increase, but to a lesser degree (P<0.01), in the frequency of SCEs and chromosome aberrations while the drug combination of dapsone, rifampicin and clofazamine had a non-mutagenic effect on chromosomes of the patient. Furthermore, after drug treatment, the cell proliferation rate and mitotic indices in paucibacillary patients were comparable to that of controls. These results indicate the clastogenic potency ofMycobacterium lepraeand the remedial effects that follow therapeutic drug treatment.

著录项

  • 来源
    《Human Genetics》 |1991年第6期|665-670|共页
  • 作者

    DorisDSouza; B.C.Das; I.M.Thomas;

  • 作者单位

    St. John's Medical College;

    Institute of Cytology and Preventive Oncology (ICMR), Maulana Azad Medical College Campus;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 英语
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号